AOAC SPADA Meeting
What is the objective and points to consider for the WG • Objective: Evolve a standard for use of in silico approaches in assay development • Set parameters needed for in silico approach • What are the steps that can be modified/eliminated? • Cost? • What are the broad categories of information to be captured? • What is the outline of the document- this is not the usual run of the mill SMPR. • Document type: Standards/ guidelines/ recommendations/ manuscript • What is the venue to publish? AOAC, ASM Science, Genomics, Techniques
2018_10_17_SPADA_Brief
25
CONTACT US
Bruce Goodwin Joint Product Leader bruce.g.goodwin4.civ@mail.mil Bryan Necciai
Assistant Product Manager bryan.d.necciai.civ@mail.mil Shanmuga Sozhamannan, Ph. D Technical Coordinator email: shanmuga.sozhamannan.ctr@mail.mil https://www.ncbi.nlm.nih.gov/pubmed/?term=Sozhamannan
This work was funded by DUSA-TE and JPEO JPM Guardian, DBPAO
2018_10_17_SPADA_Brief
UNCLASSIFIED
26
Made with FlippingBook Learn more on our blog